Skip to main
CAH

Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health (CAH) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 58%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

Cardinal Health is well-established in the US pharmaceutical wholesale industry and is actively expanding into new markets and services to drive growth. With a solid distribution network and strong management, the company is well-positioned to continue delivering solid financial results and potentially exceed industry expectations. Despite some challenges, Cardinal Health appears poised for long-term success and presents a positive investment opportunity.

Bears say

Cardinal Health is expected to face significant challenges in the near future due to potential changes in pricing and reimbursement models and its reliance on a few major customers. However, its specialized and differentiated business platforms and expansion into underpenetrated specialty markets may help mitigate these risks. Additionally, the company's strength in its at-home solutions and logistics businesses and its leading position in the market are expected to drive growth and improve its margin profile.

Cardinal Health (CAH) has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 58% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cardinal Health (CAH) Forecast

Analysts have given Cardinal Health (CAH) a Buy based on their latest research and market trends.

According to 12 analysts, Cardinal Health (CAH) has a Buy consensus rating as of Jun 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $226.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $226.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cardinal Health (CAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.